Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
4.10
-0.51 (-11.06%)
At close: Aug 15, 2025, 12:44 PM
Vivos Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.58 | -2.23 | -1.65 | -0.99 | -0.52 | -1.34 | -0.69 | -0.69 | 0.44 | -0.32 | -0.63 | -0.98 | -3.38 | -0.64 | -3.86 | -6.35 | -8.89 |
PEG Ratio | 0.01 | 0.01 | 0.05 | 0.02 | 0.02 | -0.04 | 0.01 | 0.00 | -0.00 | -0.01 | 0.03 | -0.01 | 0.04 | -0.00 | -0.11 | -1.48 | 0.15 |
PS Ratio | 8.12 | 6.83 | 4.47 | 1.88 | 2.28 | 7.02 | 1.74 | 4.50 | 2.19 | 2.34 | 3.25 | 6.55 | 16.45 | 11.78 | 18.51 | 22.83 | 35.07 |
PB Ratio | 5.56 | 3.18 | 2.25 | 1.20 | 13.37 | 55.51 | 124.93 | 7.25 | 1.21 | 1.93 | 1.40 | 1.85 | 2.73 | 2.03 | 2.59 | 2.81 | 8.43 |
P/FCF Ratio | -6.45 | -8.14 | -4.34 | -2.45 | -2.92 | -7.83 | -1.95 | -4.92 | -2.24 | -2.89 | -2.32 | -5.3 | -9.18 | -11.49 | -18.7 | -20.51 | -29.33 |
P/OCF Ratio | -6.45 | -8.59 | -4.12 | -2.5 | -3.09 | -8.3 | -2.05 | -5.34 | -2.39 | -3.08 | -2.36 | -5.87 | -9.36 | -12.56 | -20.73 | -27.79 | -31.32 |
OCF/S Ratio | -1.26 | -0.8 | -1.08 | -0.75 | -0.74 | -0.85 | -0.85 | -0.84 | -0.92 | -0.76 | -1.38 | -1.11 | -1.76 | -0.94 | -0.89 | -0.82 | -1.12 |
Debt / Equity Ratio | 0.32 | 0.19 | 0.21 | 0.28 | 3.23 | 4.85 | 45.74 | 1.05 | 0.33 | 0.50 | 0.29 | 0.20 | 0.11 | 0.06 | 0.04 | 0.03 | 0.09 |
Quick Ratio | 0.77 | 1.50 | 1.44 | 1.18 | 0.45 | 0.34 | 0.28 | 0.63 | 1.09 | 0.80 | 1.63 | 2.32 | 3.15 | 3.64 | 4.16 | 4.23 | 2.29 |
Current Ratio | 0.77 | 1.50 | 1.44 | 1.18 | 0.45 | 0.34 | 0.28 | 0.63 | 1.09 | 0.80 | 1.63 | 2.32 | 3.15 | 3.64 | 4.15 | 4.23 | 2.29 |
Asset Turnover | 0.27 | 0.24 | 0.25 | 0.26 | 0.29 | 0.30 | 0.32 | 0.25 | 0.23 | 0.29 | 0.23 | 0.17 | 0.12 | 0.13 | 0.11 | 0.10 | 0.16 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -1.3 | n/a | n/a | n/a | -233.19 | -200.26 | -248.71 | n/a | -1.56K | -579.95 | -16.18K | -41.55K |
Return on Equity | -0.88 | -0.36 | -0.34 | -0.3 | -6.47 | -10.36 | -45.5 | -2.62 | 0.68 | -1.52 | -0.55 | -0.47 | -0.2 | -0.79 | -0.17 | -0.11 | -0.24 |
Return on Assets | -0.34 | -0.18 | -0.17 | -0.12 | -0.32 | -0.4 | -0.2 | -0.4 | 0.28 | -0.53 | -0.3 | -0.29 | -0.14 | -0.6 | -0.13 | -0.09 | -0.15 |
Return on Invested Capital | -0.53 | -0.25 | -0.25 | -0.19 | -1.07 | -0.98 | -0.97 | -0.73 | 1.40 | -0.94 | -0.41 | -0.38 | -0.22 | -0.65 | -0.16 | -0.11 | -0.21 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.50 | 0.57 | 0.60 | 0.65 | 0.57 | 0.55 | 0.57 | 0.62 | 0.61 | 0.60 | 0.59 | 0.62 | 0.68 | 0.71 | 0.70 | 0.81 | 0.78 |
Net Profit Margin | -1.28 | -0.76 | -0.68 | -0.48 | -1.1 | -1.31 | -0.63 | -1.63 | 1.24 | -1.85 | -1.29 | -1.68 | -1.22 | -4.61 | -1.2 | -0.9 | -0.99 |
Pretax Profit Margin | -1.28 | -0.76 | -0.68 | -0.48 | -1.1 | -1.31 | -0.63 | -1.63 | -0.44 | -1.54 | -1.28 | -1.67 | -1.59 | -1.68 | -1.2 | -0.9 | -0.99 |
Operating Profit Margin | -1.24 | -0.76 | -0.69 | -0.48 | -1.06 | -1.32 | -1.06 | -1.33 | -1.3 | -1.53 | -1.27 | -1.66 | -1.97 | -1.48 | -1.21 | -0.9 | -0.99 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.18 | -0.72 | -0.65 | -0.44 | -1.06 | -1.27 | -1.06 | -1.29 | -1.25 | -1.5 | -1.23 | -1.6 | -1.87 | -1.64 | -1.16 | -0.86 | -0.93 |